Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Federated Kaufmann Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 32
Average round size
info
The average size of a deal this fund participated in
$273M
Portfolio companies 30
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.06
Exits 21
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Medical
Summary

The typical case for the fund is to invest in rounds with 7 participants. Despite the Federated Kaufmann Fund, startups are often financed by Sutter Hill Ventures, Topspin Partners, Three Arch Partners. The meaningful sponsors for the fund in investment in the same round are Windamere Venture Partners, St. Paul Venture Capital, Section 32. In the next rounds fund is usually obtained by Warburg Pincus, St. Paul Venture Capital, RWI Group.

The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Alector, Dexcom, Cytokinetics, Inc.. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Biopharma, Enterprise Software.

This Federated Kaufmann Fund works on 71 percentage points more the average amount of lead investments comparing to the other organizations. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018. The top amount of exits for fund were in 2005. The common things for fund are deals in the range of 50 - 100 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Federated Kaufmann Fund:
Typical Co-investors
Federated Kaufmann Fund is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Federated Kaufmann Fund:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Compaq California, Palo Alto, United States
DRL Capital -
k16 Ventures Berlin, Berlin, Germany
Kenetic China, Hong Kong, Hong Kong Island
Klein Private Equity Investment -
MassAve Global New York, New York, United States
Montis Capital Boulder, Colorado, United States
Nizar AlNusif Sons Holding -
Philippine National Bank Pasay, Pasay City, Philippines
Revolution Health District of Columbia, United States, Washington
Sharq Ventures House -
Taiho Pharmaceutical Co Japan, Tokyo
The Baobab Network England, London, United Kingdom
Tsadik Foundation -
UK Innovation & Science Seed Fund Harwell, Oxfordshire, United Kingdom
United Internet Ventures Germany, Rheinland-Pfalz, Rhineland-Palatinate
University of Central Florida Business Incubation Program Florida, Orlando, United States
Walls Capital -
Wit SoundView Ventures New York, New York, United States
Woowa Bros Seoul, Seoul-t'ukpyolsi, South Korea

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Laronde

Biotechnology
Medical
Therapeutics
$440M30 Aug 2021 Cambridge, Massachusetts, United States

CeQur

Biotechnology
Delivery
Diabetes
Health Care
Medical
Medical Device
$115M13 Apr 2021 Lucerne, Switzerland

Biotechnology
Health Care
Health Diagnostics
Therapeutics
$160M03 Mar 2021 Philadelphia, Pennsylvania, United States

Dexcom

Biotechnology
Health Care
Manufacturing
Medical Device
$30M03 Jun 2002 San Diego, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Federated Kaufmann Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 32
Average round size 273M
Peak activity year 2021
Lead investments 0
Follow on index 0.06
Exits 21
Group Appearance index 0.97

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Laronde

Biotechnology
Medical
Therapeutics
$440M30 Aug 2021 Cambridge, Massachusetts, United States

CeQur

Biotechnology
Delivery
Diabetes
Health Care
Medical
Medical Device
$115M13 Apr 2021 Lucerne, Switzerland

Biotechnology
Health Care
Health Diagnostics
Therapeutics
$160M03 Mar 2021 Philadelphia, Pennsylvania, United States

Dexcom

Biotechnology
Health Care
Manufacturing
Medical Device
$30M03 Jun 2002 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: